Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

Leukemia

Volumn 27, Issue 5, 2013, Pages 1139-1145

  Vanderwalde, A M ^a   Sun, C L ^b   Laddaran, L ^b   Francisco, L ^b   Armenian, S ^b   Berano Teh, J ^b   Wong, F L ^b   Popplewell, L ^b   Somlo, G ^a   Stein, A S ^a   Nademanee, A ^a   Krishnan, A ^a   Kogut, N ^a   Forman, S J ^a   Bhatia, S ^a,b  

^a City of Hope ^*  (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

autologous HCT; cause specific mortality; conditional survival

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE SPECIFIC MORTALITY; CHILD; COHORT ANALYSIS; CONDITIONAL SURVIVAL; CONFIDENCE INTERVAL; FEMALE; HEART DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; STANDARDIZED MORTALITY RATIO; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 84877617679     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2012.311     Document Type: Article

References (39)

1. Appelbaum F, Herzig G, Ziegler J, Graw R, Levine A, Deisseroth A. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85-95.
2. Horowitz M (ed) Uses and Growth of Hematopoietic Cell Transplantation. Blackwell: Malden, MA, 2004.
3. Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 2005; 105: 4215-4222.
4. Henson D, Ries L, Carriaga M. Conditional survival of 56,268 patients with breast cancer. Cancer 1995; 76: 237-242.
5. Merrill R, Henson D, Ries L. Conditional survival estimates in 34,963 patients with invasive carcinoma of the colon. Dis Colon Rectum 1998; 41: 1097-1106.
6. Skuladottir H, Olsen J. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003; 21: 3035-3040.
7. Wang S, Emery R, Fuller D, Kim J, Sittig D, Thomas C. Conditional survival of gastric cancer: a SEER database analysis. Gastric Cancer 2007; 10: 153-158.
8. Janssen-Heijnen ML, van Steenbergen LN, Steyerberg E, Visser O, De Ruysscher DK, Groen HJ. Long-term excess mortality for survivors of non-small cell lung cancer in the Netherlands. J Thorac Oncol 2012; 7: 496-502.
9. Bouvier AM, Remontet L, Hedelin G, Launoy G, Jooste V, Grosclaude P et al. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis. Cancer 2009; 115: 4616-4624.
10. Marsh G, Ehland J, Sefcik S, Youk A. Mortality and Population Data System. University of Pittsburgh: Pittsburgh, PA, 2000.
11. Breslow N, Day N. Fitting Models to Grouped Data. Statistical Methods in Cancer Research Vol 2. International Agency for Research on Cancer. IARC Scientific Publications, No. 82: Lyon, France, 1987.
12. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimates. Stat Med 1999; 18: 695-706.
13. Nivison-Smith I, Simpson JM, Dodds AJ, Ma DDF, Szer J, Bradstock KF. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates. Biol Blood Marrow Transplant 2009; 15: 1323-1330.
14. Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P et al. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT). Leukemia 1991; 5: 896-904.
15. Sun CL, Francisco L, Kawashima T, Leisenring W, Robison LL, Baker KS et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 2010; 116: 3129-3139.
16. Hill BT, Rybicki L, Bolwell BJ, Smith S, Dean R, Kalaycio M et al. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls. Br J Haematol 2011; 152: 561-569.
17. Jantunen E, Itala M, Siitonen T, Koivunen E, Leppa S, Juvonen E et al. Late nonrelapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003. Eur J Haematol 2006; 77: 114-119.
18. Oddou S, Vey N, Viens P, Bardou VJ, Faucher C, Stoppa AM et al. Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution. Leuk Lymphoma 1998; 31: 187-194.
19. Krishnan A, Bhatia S, Slovak ML, Arber DA, Niland JC, Nademanee A et al. Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood 2000; 95: 1588-1593.
20. Armenian SH, Sun CL, Francisco L, Steinberger J, Kurian S, Wong FL et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol 2008; 26: 5537-5543.
21. Villani F, De Maria P, Bonfante V, Viviani S, Laffranchi A, Dell'oca I et al. Late pulmonary toxicity after treatment for Hodgkin's disease. Anticancer Res 1997; 17: 4739-4742.
22. Kalaycio M, Pohlman B, Kuczkowski E, Rybicki L, Andresen S, Sobecks R et al. High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant. Clin Transplant 2006; 20: 783-787.
23. Chen CI, Abraham R, Tsang R, Crump M, Keating A, Stewart AK. Radiation-associated pneumonitis following autologous stem cell transplantation: predictive factors, disease characteristics and treatment outcomes. Bone Marrow Transplant 2001; 27: 177-182.
24. Jules-Elysee K, Stover DE, Yahalom J, White DA, Gulati SC. Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. Am Rev Respir Dis 1992; 146: 485-491.
25. Bowles TL, Xing Y, Hu CY, Mungovan KS, Askew RL, Chang GJ et al. Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol 2010; 17: 2015-2023.
26. Moller MB, Pedersen NT, Christensen BE. Conditional survival of patients with diffuse large B-cell lymphoma. Cancer 2006; 106: 2165-2170.
27. Ellison LF, Bryant H, Lockwood G, Shack L. Conditional survival analyses across cancer sites. Health Rep 2011; 22: 21-25.
28. Baade PD, Youlden DR, Chambers SK. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 2011; 194: 73-77.
29. Janssen-Heijnen ML, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H et al. Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol 2010; 28: 2520-2528.
30. Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist 2010; 15: 873-882.
31. Sant M, Allemani C, Santaguiklani M, Knijn A, Marchesi F, Capocaccia R et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-991.
32. Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol 2009; 27: 5938-5943.
33. Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE et al. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 2010; 116: 2234-2241.
34. Meng L, Maskarinec G, Lee J. Ethnicity and conditional breast cancer survival in Hawaii. J Clin Epidemiol 1997; 50: 1289-1296.
35. Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D et al. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 2011; 29: 2230-2239.
36. Martin PJ, Counts Jr GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg J et al. Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 2010; 28: 1011-1016.
37. Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M et al. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic phase. J Clin Oncol 2010; 28: 1888-1895.
38. Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ et al. Longterm survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. Br J Haematol 2009; 147: 129-139.
39. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784-3792.